AI for Alzheimer’s

Our deep learning platform will analyse structural MRI images and PET scans with the objective of detecting signs of E-MCI (Early Mild Cognitive Impairment). The analysis will cover different regions of the brain and their association with the disease, including biomarkers associated with Alzheimer’s. These efforts have the potential to start a patient’s drug treatment 10 years prior to when they would begin if they had been detected at the full-blown Alzheimer’s stage.